Global Longlife Hospital & Research (BOM:543520) OCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543520 Global Longlife Hospital & Research Ltd BOM:543520
36 GF Score
Price ₹13.04
GF Value ₹1.37
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Global Longlife Hospital & Research OCF Margin %?

Global Longlife Hospital & Research BOM:543520 -1.81% 36 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:543520 with a GF Score™ of 36/100 and a GF Value™ of ₹1.37 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 666 Healthcare Providers & Services companies, Global Longlife Hospital & Research ranks worse than 150150% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Global Longlife Hospital & Research's Cash Flow from Operations for the six months ended in Mar. 2026 was ₹-40.63 Mil. Global Longlife Hospital & Research's Revenue for the six months ended in Mar. 2026 was ₹0.00 Mil. Therefore, Global Longlife Hospital & Research's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Global Longlife Hospital & Research's current OCF Yield % is -35.20%.

The historical rank and industry rank for Global Longlife Hospital & Research's OCF Margin % or its related term are showing as below:


During the past 8 years, the highest OCF Margin % of Global Longlife Hospital & Research was 2134.19%. The lowest was -171.97%. And the median was 15.63%.

BOM:543520's OCF Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 8.27
* Ranked among companies with meaningful OCF Margin % only.

Global Longlife Hospital & Research OCF Margin % Related Terms

Global Longlife Hospital & Research OCF Margin % Historical Data

* Premium members only.

The historical data trend for Global Longlife Hospital & Research's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Longlife Hospital & Research OCF Margin % Chart

Global Longlife Hospital & Research Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial 28.72 -171.97 -37.53 2,134.19 0.00

Global Longlife Hospital & Research Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -316.07 2,802.39 0.00 0.00 0.00
BOM:543520
36GF Score
Global Longlife Hospital & Research Ltd BOM:543520
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Longlife Hospital & Research OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Global Longlife Hospital & Research's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-45.097/0
= %

Global Longlife Hospital & Research's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-40.625/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Global Longlife Hospital & Research (BOM:543520) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Global Longlife Hospital & Research and its competitors. According to the industry distribution chart, Global Longlife Hospital & Research ranks #999999 out of 666 companies in the Healthcare Providers & Services industry.
Is Global Longlife Hospital & Research's OCF Margin % too high?
Global Longlife Hospital & Research's current OCF Margin % is 0.00%. Based on the distribution chart, Global Longlife Hospital & Research ranks #999999 out of 666 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Global Longlife Hospital & Research has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Global Longlife Hospital & Research's OCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Longlife Hospital & Research ranks #999999 out of 666 companies for OCF Margin %. This places Global Longlife Hospital & Research in the lower half of its industry. The industry median OCF Margin % is 8.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.27, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Global Longlife Hospital & Research and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Longlife Hospital & Research's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Longlife Hospital & Research stock overvalued right now?
Based on GuruFocus' analysis, Global Longlife Hospital & Research (BOM:543520) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1.37, compared to a current price of ₹13.04 — trading 851.8% above its estimated fair value. The current OCF Margin % is 0.00%. Global Longlife Hospital & Research's overall GF Score™ is 36/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Global Longlife Hospital & Research (BOM:543520), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Global Longlife Hospital & Research (BOM:543520) Overvalued in 2026?

Based on GuruFocus' analysis, Global Longlife Hospital & Research stock appears to be overvalued. The current stock price of ₹13.04 is trading 851.8% above its estimated GF Value™ of ₹1.37. GuruFocus considers Global Longlife Hospital & Research to be Significantly Overvalued.

Key valuation signals for BOM:543520:

  • OCF Margin %: 0.00%
  • GF Value™: ₹1.37 vs. price of ₹13.04 (851.8% above fair value)
  • GF Score™: 36/100 with 1 warning sign

No single metric tells the full story. See the BOM:543520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Global Longlife Hospital & Research Business Description

Address Sindhu Bhavan Road, Beside Taj Skyline, 703, Sankalp Square, 3B, Ahmedabad, GJ, IND, 380 059
Global Longlife Hospital & Research Ltd is Multispecialty Hospital providing Medical & Allied Services. The company operates in the single segment i.e. Health Care and Hospital. Its services are Medical, Surgical, Radiology, Pathology, and Other Services.
36GF Score

Get the complete analysis for BOM:543520

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.04
Price
₹1.37
GF Value